Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics

dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica
dc.contributor.affiliationUniversidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CiMUS)
dc.contributor.affiliationUniversidade de Santiago de Compostela. Instituto de Materiais (iMATUS)
dc.contributor.authorCuartero Martínez, Andrea
dc.contributor.authorGarcía Otero, Xurxo
dc.contributor.authorCodesido, Jessica
dc.contributor.authorGómez Lado, Noemí
dc.contributor.authorMateos, Jesús
dc.contributor.authorBravo, Susana B.
dc.contributor.authorRodríguez-Fernández, Carmen Antía
dc.contributor.authorGonzález Barcia, Miguel
dc.contributor.authorAguiar Fernández, Pablo
dc.contributor.authorOrtega-Hortas, Marcos
dc.contributor.authorOtero Espinar, Francisco Javier
dc.contributor.authorFernández Ferreiro, Anxo
dc.date.accessioned2025-02-19T11:49:23Z
dc.date.available2025-02-19T11:49:23Z
dc.date.issued2024-07-25
dc.description.abstractUveitis is a group of inflammatory ocular pathologies. Endotoxin-Induced Uveitis (EIU) model represent a well-known model induced by administration of Lipopolysaccharide (LPS). The aim is to characterize two models of EIU through two routes of administration with novel noninvasive imaging techniques. 29 rats underwent Intraocular Pressure (IOP) measurements, Optical Coherence Tomography (OCT), proteomic analysis, and Positron Emission Tomography and Computed Tomography (PET/CT). Groups included healthy controls (C), BSS administered controls (Ci), systemically induced EIU with LPS (LPSs), and intravitreally induced EIU with LPS (LPSi) for IOP, OCT, and proteomic studies. For 18F-FDG PET/CT study, animals were divided into FDG-C, FDG-LPSs and FDG-LPSi groups and scanned using a preclinical PET/CT system. LPSi animals exhibited higher IOP post-induction compared to C and LPSs groups. LPSi showed increased cellular infiltrate, fibrotic membranes, and iris inflammation. Proinflammatory proteins were more expressed in EIU models, especially LPSi. PET/CT indicated higher eye uptake in induced models compared to FDG-C. FDG-LPSi showed higher eye uptake than FDG-LPSs but systemic uptake was higher in FDG-LPSs due to generalized inflammation. OCT is valuable for anterior segment assessment in experimental models. 18F-FDG PET/CT shows promise as a noninvasive biomarker for ocular inflammatory diseases. Intravitreal induction leads to higher ocular inflammation. These findings offer insights for future inflammatory disease research and drug studies.
dc.description.peerreviewedSI
dc.description.sponsorshipThis work was partially supported by Instituto de Salud Carlos III (ISCIII, Spain) through PI20/00719 project, Axencia Galega de Innovación (Grupos de Potencial Crecimiento IN607B2020/11, Spain), Ministry of Science and Innovation of Spain (MICINN, Spain) through PID2022-142350OB-C21 project and Xunta de Galicia (Grupo de Referencia Competitiva, ED431C 2021/26, Spain). X. García-Otero and J. Mateos acknowledges the support of Xunta de Galicia (Spain) through the postdoctoral fellowship [ED481B-2023-063] and Senior Talent Research grant [11-IN858A_2021_1141142]. J. Codesido is grateful to the Health Research Institute of Santiago de Compostela (IDIS, Spain) for financing his predoctoral research fellowship.
dc.identifier.citationReferences Cuartero-Martínez, A., García-Otero, X., Codesido, J., Gómez-Lado, N., Mateos, J., Bravo, S. B., Rodríguez-Fernández, C. A., González-Barcia, M., Aguiar, P., Ortega-Hortas, M., Otero-Espinar, F. J., & Fernández-Ferreiro, A. (2024). Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics. International Journal of Pharmaceutics, 66210.1016/j.ijpharm.2024.124516
dc.identifier.doi10.1016/j.ijpharm.2024.124516
dc.identifier.essn1873-3476
dc.identifier.issn0378-5173
dc.identifier.urihttps://hdl.handle.net/10347/39754
dc.journal.titleInternational Journal of Pharmaceutics
dc.language.isoeng
dc.publisherElsevier
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2022-142350OB-C21/ES/I+D DE SISTEMAS ESPECIALIZADOS DE LIBERACION DE FARMACOS PARA EL TRATAMIENTO DE PATOLOGIAS INFLAMATORIAS Y DEGENERATIVAS OCULARES/
dc.relation.publisherversionhttps://doi.org/10.1016/j.ijpharm.2024.124516
dc.rights© 2024 The Author(s). Published by Elsevier B.V
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectModel characterization
dc.subjectEndotoxin-induced uveitis models
dc.subjectOcular inflammatory diseases
dc.subjectOCT imaging
dc.subjectProteomics
dc.subjectPET/CT imaging
dc.titlePreclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number662
dspace.entity.typePublication
relation.isAuthorOfPublicationf0a02245-3bba-4bfb-8172-5f0e3b2f20fe
relation.isAuthorOfPublication6a1630c3-8a68-4656-9fac-695b76a69303
relation.isAuthorOfPublicatione1eb8f2f-9516-4a0f-8819-2cad31053b62
relation.isAuthorOfPublication.latestForDiscoveryf0a02245-3bba-4bfb-8172-5f0e3b2f20fe

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2024_Ijpharm_Otero-Espinar_Preclinical.pdf
Size:
4.99 MB
Format:
Adobe Portable Document Format